These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6414555)

  • 1. Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII.
    Lusher JM; Blatt PM; Penner JA; Aledort LM; Levine PH; White GC; Warrier AI; Whitehurst DA
    Blood; 1983 Nov; 62(5):1135-8. PubMed ID: 6414555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROPLEX vs. PROPLEX SX: a controlled double blind study of the effectiveness in treating acute hemarthroses in hemophilia A patients with inhibitors to factor VIII.
    Gomperts ED; Fannon RB; Lee ML; Kingdon HS; Kantrowitz JL; Addiego JE; Carney J; Corrigan JJ; Hathaway W; Hilgartner MW
    Thromb Res; 1986 Jun; 42(6):789-96. PubMed ID: 3726800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled clinical trials with prothrombin complex concentrates.
    Lusher JM
    Prog Clin Biol Res; 1984; 150():277-90. PubMed ID: 6431433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
    N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors.
    Lusher JM
    Scand J Haematol Suppl; 1984; 40():195-202. PubMed ID: 6433452
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
    Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ
    Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
    Verroust F; Moussard C; Allain JP
    Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
    Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
    N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of an activated factor IX complex (Autoplex) in the management of haemarthroses in haemophiliacs with antibodies to factor VIII.
    Aronstam A; McLellan DS; Mbatha PS; Wassef M
    Clin Lab Haematol; 1982; 4(3):231-8. PubMed ID: 6816500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy.
    Hutchinson RJ; Penner JA; Hensinger RN
    Pediatrics; 1983 Apr; 71(4):631-3. PubMed ID: 6601258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a heated prothrombin complex concentrate in hemophiliacs with inhibitors.
    Mannucci PM; Mari D; Pareti FI
    Thromb Haemost; 1987 Dec; 58(4):1090-1. PubMed ID: 3127920
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors.
    Hilgartner MW; Knatterud GL
    Blood; 1983 Jan; 61(1):36-40. PubMed ID: 6401216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-threatening sublingual hematoma in a severely hemophilic patient with factor VIII inhibitor.
    Takeuchi M; Shikimori M; Kaneda T
    J Oral Maxillofac Surg; 1986 May; 44(5):401-3. PubMed ID: 3084733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-partum treatment of a patient with a factor VIII inhibitor.
    Files JC; Morrison FS; Halbrook J
    N Engl J Med; 1981 Dec; 305(27):1650. PubMed ID: 6796887
    [No Abstract]   [Full Text] [Related]  

  • 19. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
    Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inhibitor Coagulant Complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia.
    Abildgaard CF; Penner JA; Watson-Williams EJ
    Blood; 1980 Dec; 56(6):978-84. PubMed ID: 6777002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.